Clinical Trial Update: Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers [Phase 3]

View source ↗

Summary

A Phase 3 safety study of Bepotastine Besilate Ophthalmic Solution was completed in normal volunteers, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• Bepotastine Besilate Ophthalmic Solution (bepotastine besilate)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Allergic Conjunctivitis | Phase 3 | Status: COMPLETED | Results posted: 2009-11-11